Accelrys Adds Scynexis' SaaS Platform to Its Cheminformatics Suite | GenomeWeb

By Uduak Grace Thomas

Accelrys said this week that it has signed a reseller agreement that enables it to sell Scynexis software-as-a-service platform as part of its Cheminformatics suite.

The company said the addition of the Hit Explorer Operating System, or HEOS, will support real-time data sharing across disparate organizations — multiple companies, academic institutions, and contract research organizations — that are engaged in collaborative drug discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.